Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan · Delayed Price · Currency is TWD 41.30
+0.10 (0.24%)
Aug 4, 2026, 12:54 PM CST
TPEX:6864 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -93.6 | -74.52 | -51.78 | -31.74 | -22.35 |
Depreciation & Amortization | 11.13 | 10.82 | 10.51 | 9.55 | 7.6 |
Loss (Gain) From Sale of Assets | 0.05 | - | - | -2.33 | - |
Stock-Based Compensation | 6.78 | 0.33 | 0.64 | - | - |
Other Operating Activities | 0.02 | 0.03 | -5.67 | -8.06 | -4.87 |
Change in Accounts Receivable | 0.46 | -0.12 | -0.33 | 0.07 | -0.07 |
Change in Inventory | 0.53 | -1.67 | -0.18 | 0.51 | -0.84 |
Change in Accounts Payable | - | -0.27 | - | -0.66 | 0.93 |
Change in Unearned Revenue | -0.06 | 0.06 | 0.13 | - | - |
Change in Other Net Operating Assets | -3.04 | 1.2 | -1.58 | 1.98 | -0.54 |
Operating Cash Flow | -77.73 | -64.15 | -48.26 | -30.66 | -20.13 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -6.81 | -8.37 | -1.52 | -7.74 | -3.29 |
Sale of Property, Plant & Equipment | - | - | - | 16.25 | - |
Sale (Purchase) of Intangibles | -0.03 | - | - | - | - |
Investment in Securities | - | 0.01 | - | - | - |
Other Investing Activities | -1.13 | 0.05 | -0.26 | -0.85 | -0.98 |
Investing Cash Flow | -7.97 | -8.32 | -1.78 | 7.66 | -4.27 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | 10 |
Long-Term Debt Repaid | -2.19 | -2.25 | -2.6 | -12.38 | -1.29 |
Net Debt Issued (Repaid) | -2.19 | -2.25 | -2.6 | -12.38 | 8.71 |
Issuance of Common Stock | 360 | 190.45 | - | - | 90 |
Other Financing Activities | -0.02 | -0.03 | -0.04 | -0.08 | -0.09 |
Financing Cash Flow | 357.79 | 188.16 | -2.65 | -12.46 | 98.62 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 272.09 | 115.7 | -52.69 | -35.47 | 74.22 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -84.53 | -72.52 | -49.78 | -38.41 | -23.41 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -11973.09% | -11850.00% | -6837.78% | -1424.03% | -26606.82% |
Free Cash Flow Per Share | -2.60 | -2.39 | -1.99 | -1.54 | -1.25 |
Levered Free Cash Flow | -48.17 | -45.85 | -30.5 | -23.65 | -13.11 |
Unlevered Free Cash Flow | -48.16 | -45.83 | -30.47 | -23.59 | -13.05 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.02 | 0.03 | 0.04 | 0.08 | 0.09 |
Cash Income Tax Paid | - | - | 0.7 | - | - |
Change in Working Capital | -2.11 | -0.8 | -1.96 | 1.9 | -0.51 |